Arlesheim, Switzerland, Friday, December 6, 2019 – The team of CIS Pharma sets out on sheer ice, armed with stone and broom. After a short introduction, we are ready to play Curling, the traditional sport from Scotland. Gradually, we know how to handle the 20 kg stones and the competition starts: In two teams we take turns sliding heavy, polished granite stones across the ice toward the house, a circular target marked on the ice. Winner is who accumulates the most stones resting closest to the centre of the house. Even with just 5 Celsius in the ice rink, everyone starts to feel the heat of the competition.
Curling is a winter sport in which players slide stones on ice toward a target area segmented into circles. Two teams, each with four players, take turns sliding granite stones across the ice toward the house, a circular target marked on the ice. Each team has eight stones, two each player. The purpose is to accumulate the highest score for the stones resting closest to the centre of the house. The word curling first appears in print in 1620 in Perth, Scotland, and is formed from the Scots verb curl, which describes the motion of the stone. Due to its strategic characteristics its nickname is chess on ice. The curling rink in Arlesheim was built in 1970 and has increased the attractiveness of curling in the region significantly. In 2002 and 2003 the rink hosted the Swiss championships. In 2003 and 2007 the teams from Basel Ysfäger and Basel Regio won the Swiss championship titles and represented Switzerland at the World Championships. In 2006 the European Championship was held in Basel with games in the curling rink in Arlesheim.
About CIS Pharma AG
CIS Pharma AG is an innovator in the life science industry. The company was founded in 1952 and is family owned. In our laboratories, we synthesize novel molecules, develop new biomaterials and create cutting-edge medical devices. Our mission is to improve the risk-benefit profile of therapeutics that are the standard of care, thereby improving patient’s experience and treatment outcome. Medical need, patient centricity and digital technology are key to our research and development programs. CIS Pharma is located in the region of Basel, Switzerland, one of the most successful life sciences locations in the world. For more information about the company, visit our website www.cis-pharma.com.